Aprea Therapeutics
APRE
HK$14.77
Share price
0.63%
Change (1 day)
-52.72%
Change (1 year)
Categories
EPS for Aprea Therapeutics (APRE)
EPS in 2025 (TTM): -HK$18.44
According to Aprea Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$18.60. In 2024 the company made an earnings per share (EPS) of -HK$18.68.
EPS history for Aprea Therapeutics from 2019 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | -HK$18.44 | -1.27% |
| 2024 | -HK$18.68 | |
| 2022 | -HK$763.02 | 177.74% |
| 2021 | -HK$274.72 | -31.1% |
| 2020 | -HK$398.74 | 70.91% |
| 2019 | -HK$233.30 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Healthcare Services Group HCSG | HK$4.40 | -123.63% | 🇺🇸 USA |
 Amedisys AMED | HK$21.59 | -216.03% | 🇺🇸 USA |